Navigation Links
IRIDEX Reports 2012 First Quarter Results
Date:5/3/2012

fact, demand for our G-Probe™ stepped up considerably in the period, outstripping supply and resulting in a modest backlog for the period."

Beck continued, "We are increasing our investment in people and programs to make the necessary product and organizational changes that will drive sales growth. We intend to balance our investments in line with our revenue growth to maintain profitability for the year."

"I believe there are a number of very promising trends in the ophthalmic space and that these trends can be turned into substantial growth opportunities for IRIDEX and allow us to grow faster than our historical rates. We are uniquely positioned as the only US public company with an exclusive focus on the large and growing retinal disease and glaucoma markets to capitalize on those opportunities."

During the first quarter 2012, the Company continued to execute its share repurchase program. Since the beginning of 2011, approximately 157,000 shares have been repurchased at an average price of $3.90. The Board of Directors has approved an extension of the Company's share repurchase program through March 2013 and an increase in the amount of cash available for the program to a total of $4 million.

Recent  Business Highlights

  • The Company closed the sale of its aesthetics business to Cutera, Inc. for approximately $5.1 million. The sale allows the resources of the entire organization to now focus on the substantial and growing opportunity in the worldwide retina and glaucoma markets.
  • The Company announced the results of a clinical study evaluating the use of IRIDEX' MicroPulse laser therapy to treat central serous chorioretinopathy (CSC), an eye disease which results in vision problems. The study concluded tissue-sparing MicroPulse laser is superior to anti-VEGF injections for CSC, also known as CSR.
  • The Company hired Ron Steckel as VP of Operations. Prior to joining IRIDEX, Mr. Steckel had exp
    '/>"/>

  • SOURCE IRIDEX Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
    2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
    3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
    4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
    5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
    6. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
    7. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
    8. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
    9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
    10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
    11. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2015)... April 27, 2015 Numerous Zofran birth defects ... the U.S. have highlighted serious concerns surrounding the use ... According to the U.S. Centers for Disease Control ... the market have enough information to determine their safety ... expectant mothers in the U.S. take at least one ...
    (Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
    (Date:4/27/2015)... Pa. , April 27, 2015  SCILEX ... and commercialization of products focused on the treatment ... team of William Stewart and ... important steps in SCILEX,s proprietary drug development program ... its products. The Company,s first product, ZTlido™ (lidocaine ...
    Breaking Medicine Technology:Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4SCILEX Pharmaceuticals Announces Commercial Executive Appointments 2SCILEX Pharmaceuticals Announces Commercial Executive Appointments 3
    (Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the ... Psychiatric Publishing, a division of the American Psychiatric Association. ... National Press Club in Washington, D.C.. The launch event ... President Paul Summergrad, MD. Guest speakers will include Former ... the book; Paul Gionfriddo, President and CEO of Mental ...
    (Date:4/27/2015)... CA (PRWEB) April 27, 2015 On April ... to Get Rid of Stretch Marks ,” interviewed a ... marks . Stretch marks are a type of ... marks are caused by a breakdown of the elsastin and ... epidermis. (see: goo.gl/iRdmEe) , “Stretch mark removal with the ...
    (Date:4/27/2015)... Beckman Coulter is sponsoring a ... the evolution of neural circuitry and swimming behavior of ... mechanisms by which analogous forms of swimming behavior, such ... independently in certain sea slug clades. The webinar is ... 30, 2015 at 8:00am PT. , Sea slugs (Mollusca, ...
    (Date:4/27/2015)... (PRWEB) April 27, 2015 Sitting or standing ... ache and feel tired, and for those whose occupation requires ... receptionists and taxi cab drivers, or to be on their ... hairdressers, the discomfort can be more severe and longer lasting. ... leg syndrome. Dr. Madaiah Revana of Northeast Houston Vein Center ...
    (Date:4/27/2015)... FMC Corporation’s Health and Nutrition business announced ... market leading ingredients and solutions at Vitafoods Europe from ... Europe 2015 expects to host 14,000 attendees and 750 ... in such areas as digestive health, heart health, healthy ... Nutrition’s booth will feature its world leading Epax® brand ...
    Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2
    ... The developer of a product, known as ALKA-V6, a ... research as a potential cancer fighting weapon, has been named ... Arts at Texas State University. , Ignacius Cisneros, of Odessa, ... Alumni and business leaders. , In inviting Cisneros to participate, ...
    ... ... their shut-off products in an industrial gray color. , ... Loveland, CO (Vocus) October 30, 2009 -- Kent Systems is now ... offered were in patriotic red, white, and blue as well as black. The color selections ...
    ... , ... analyzes myths concerning alpine skiing injuries , ... Rosemont, IL (Vocus) October 30, 2009 -- Alpine skiing is ... crash videos replayed during the evening sports casts. However, a new study published in ...
    ... Findings from a new retrospective cohort study presented at ... in San Diego indicate that patients with Inflammatory Bowel ... medications to treat IBD, may be at risk for ... of the University of North Carolina, Chapel Hill, and ...
    ... ... increase the efficiency of inactivating 99.9% of the flu virus. The filter has been ... extracts. , ... CA (PRWEB) October 29, 2009 -- Coway ,s new anti-flu air filter ...
    ... 29 The Ensign Group, Inc. (Nasdaq: ENSG ... skilled nursing, rehabilitative care services, hospice care and assisted ... the Oppenheimer & Co. 20th Annual Healthcare Conference on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the ...
    Cached Medicine News:Health News:Texas State University Names Developer of ALKA-V6 Compound to Board of Advisors 2Health News:Skiing Not As Dangerous as Believed 2Health News:Skiing Not As Dangerous as Believed 3Health News:Skiing Not As Dangerous as Believed 4Health News:Study reveals possible link between IBD therapy and skin cancer 2Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2
    ... Wormington NP Card is specially designed to be ... the older Rosenbaum card (as noted by Horton ... corrected. The "J" notations are not used because ... notation. Using the Wormington NP Card, the examiner ...
    Spanish reading test....
    Standard reading test. "Clearing weather..."...
    ... The PowerLab 4/25 is an economically ... for teaching and research use in ... physiology, pharmacology, neurophysiology, biology, zoology, biochemistry ... supports all ADInstruments signal conditioners and ...
    Medicine Products: